Sudarshan Pharma Industries Ltd - 543828 - Annual General Meeting Of The Company On Tuesday, 22/September/2026BSE filing · raw filing ↗
26 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
22 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
19 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-AllotmentBSE filing · raw filing ↗
18 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
18 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - FCCB Committee Meeting On Wednesday, 19-August-2026BSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-AcquisitionBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-AcquisitionBSE filing · raw filing ↗
12 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹174 Cr (+20.1% YoY), PAT ₹6 Cr (+41.7% YoY)BSE filing · raw filing ↗
10 Aug 2026
⚑ Filing
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
9 Aug 2026
⚑ Result
Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026BSE filing · raw filing ↗
14 Jul 2026
⚑ Filing
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
